Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric L Simpson

Showing results (81-90 of 314) with videos related to

Pageof 32
Sort By:
Dermatology and Therapy|November 22, 2021
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 WeeksAndrew Blauvelt, Marjolein de Bruin-Weller, Eric L Simpson, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Atopic dermatitis: epidemiology and pathogenesis updateLawrence F Eichenfield, Charles N Ellis, Anthony J Mancini, et al.
Dermatology (Basel, Switzerland)|August 14, 2023
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic DermatitisMichael E Jacobson, Ian A Myles, Amy S Paller, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Treatment strategies for atopic dermatitis: optimizing the available therapeutic optionsAmy S Paller, Eric L Simpson, Lawrence F Eichenfield, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Improving the patient-clinician and parent-clinician partnership in atopic dermatitis managementAnthony J Mancini, Amy S Paller, Eric L Simpson, et al.
The Journal of Investigative Dermatology|September 12, 2025
Aberrant Epidermal Innervation in Adults with Atopic Dermatitis Is Restored after Dupilumab TreatmentGina N Bash, Wenelia Baghoomian, Rishi Seshadri, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Current issues in atopic comorbidities and preventing the atopic marchEric L Simpson, Lawrence F Eichenfield, Charles N Ellis, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Understanding and managing atopic dermatitis in adult patientsCharles N Ellis, Anthony J Mancini, Amy S Paller, et al.
Dermatology and Therapy|May 20, 2026
Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled AnalysisJonathan I Silverberg, Eric L Simpson, Saleem A Farooqui, et al.
Dermatology and Therapy|July 23, 2023
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical PracticeMelinda J Gooderham, Andrew E Pink, Eric L Simpson, et al.
Pageof 32

Showing results (81-90 of 314) with videos related to

Sort By:
Pageof 32
Dermatology and Therapy|November 22, 2021
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 WeeksAndrew Blauvelt, Marjolein de Bruin-Weller, Eric L Simpson, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Atopic dermatitis: epidemiology and pathogenesis updateLawrence F Eichenfield, Charles N Ellis, Anthony J Mancini, et al.
Dermatology (Basel, Switzerland)|August 14, 2023
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic DermatitisMichael E Jacobson, Ian A Myles, Amy S Paller, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Treatment strategies for atopic dermatitis: optimizing the available therapeutic optionsAmy S Paller, Eric L Simpson, Lawrence F Eichenfield, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Improving the patient-clinician and parent-clinician partnership in atopic dermatitis managementAnthony J Mancini, Amy S Paller, Eric L Simpson, et al.
The Journal of Investigative Dermatology|September 12, 2025
Aberrant Epidermal Innervation in Adults with Atopic Dermatitis Is Restored after Dupilumab TreatmentGina N Bash, Wenelia Baghoomian, Rishi Seshadri, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Current issues in atopic comorbidities and preventing the atopic marchEric L Simpson, Lawrence F Eichenfield, Charles N Ellis, et al.
Seminars in Cutaneous Medicine and Surgery|October 2, 2012
Understanding and managing atopic dermatitis in adult patientsCharles N Ellis, Anthony J Mancini, Amy S Paller, et al.
Dermatology and Therapy|May 20, 2026
Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled AnalysisJonathan I Silverberg, Eric L Simpson, Saleem A Farooqui, et al.
Dermatology and Therapy|July 23, 2023
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical PracticeMelinda J Gooderham, Andrew E Pink, Eric L Simpson, et al.
Pageof 32